Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | LY3164530 |
Trade Name | |
Synonyms | LY-3164530|LY 3164530 |
Drug Descriptions |
LY3164530 is a bispecific antibody that targets EGFR and c-Met and inhibits activation of downstream signaling, resulting in decreased proliferation of EGFR and c-Met overexpressing tumor cells, but LY3164530 has significant toxicities (PMID: 29926131). |
DrugClasses | EGFR Antibody 56 MET Antibody 28 |
CAS Registry Number | 2069210-01-9 |
NCIT ID | C118281 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
LY3164530 | LY3164530 | 0 | 1 |